{"&cites=5558382284932309548&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","url":"https://ard.bmj.com/content/73/3/492.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2014,"numCitations":2331,"pdf":"https://ard.bmj.com/content/annrheumdis/73/3/492.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15630718529220191090&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ciNJ7q9369gJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15630718529220191090&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com","p":1,"exp":1596893545288},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","url":"https://ard.bmj.com/content/69/6/964.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2010,"numCitations":2113,"pdf":"https://ard.bmj.com/content/annrheumdis/69/6/964.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=18242945375836507497&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:aQ2X_yn2K_0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18242945375836507497&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.30129","authors":["DT Felson","DT Felson JS Smolen","DT Felson JS Smolen G Wells","DT Felson JS Smolen G Wells B Zhang…"],"year":2011,"numCitations":1363,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.30129","citationUrl":"http://scholar.google.com/scholar?cites=12290633109847859973&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:BeMi4bEZkaoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12290633109847859973&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","url":"https://ard.bmj.com/content/75/1/3.short","authors":["JS Smolen","JS Smolen FC Breedveld","JS Smolen FC Breedveld GR Burmester…"],"year":2016,"numCitations":910,"pdf":"https://ard.bmj.com/content/75/1/3.short","citationUrl":"http://scholar.google.com/scholar?cites=13812551669387189479&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:51yNr48KsL8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13812551669387189479&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/acr.21649","authors":["J Anderson","J Anderson L Caplan","J Anderson L Caplan J Yazdany…"],"year":2012,"numCitations":579,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.21649","citationUrl":"http://scholar.google.com/scholar?cites=12166801732459275383&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:d6TXk7Yp2agJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12166801732459275383&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature …","url":"https://ard.bmj.com/content/68/7/1086.short","authors":["K Visser","K Visser W Katchamart","K Visser W Katchamart E Loza…"],"year":2009,"numCitations":543,"pdf":"https://ard.bmj.com/content/annrheumdis/68/7/1086.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=7634366444820970609&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:cTy3PNW38mkJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7634366444820970609&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors …","url":"https://www.sciencedirect.com/science/article/pii/S014067361261424X","authors":["GR Burmester","GR Burmester R Blanco","GR Burmester R Blanco C Charles"],"year":2013,"numCitations":505,"citationUrl":"http://scholar.google.com/scholar?cites=1222990309883057794&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ghZTCDXv-BAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1222990309883057794&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Tofacitinib versus methotrexate in rheumatoid arthritis","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1310476","authors":["EB Lee","EB Lee R Fleischmann","EB Lee R Fleischmann S Hall…"],"year":2014,"numCitations":497,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1310476","citationUrl":"http://scholar.google.com/scholar?cites=11428537740387963843&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:w1P4HYZSmp4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11428537740387963843&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"},{"title":"Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force","url":"https://ard.bmj.com/content/73/1/6?papetoc=&int_source=trendmd&int_medium=trendmd&int_campaign=trendmd","authors":["JS Smolen","JS Smolen J Braun","JS Smolen J Braun M Dougados","JS Smolen J Braun M Dougados P Emery…"],"year":2014,"numCitations":449,"pdf":"https://ard.bmj.com/content/73/1/6?papetoc=&int_source=trendmd&int_medium=trendmd&int_campaign=trendmd","citationUrl":"http://scholar.google.com/scholar?cites=1910595556920264528&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:UAesR4nMgxoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1910595556920264528&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international task force","url":"https://ard.bmj.com/content/73/6/958.short","authors":["RF Van Vollenhoven","RF Van Vollenhoven M Mosca","RF Van Vollenhoven M Mosca G Bertsias…"],"year":2014,"numCitations":417,"pdf":"http://diposit.ub.edu/dspace/bitstream/2445/121805/1/643132.pdf","citationUrl":"http://scholar.google.com/scholar?cites=9354426477424855370&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:SslqwFGZ0YEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9354426477424855370&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"}]}